Invention Grant
- Patent Title: Microorganisms genetically engineered to have modified N-glycosylation activity
-
Application No.: US13620259Application Date: 2012-09-14
-
Publication No.: US10023854B2Publication Date: 2018-07-17
- Inventor: Nico Luc Marc Callewaert , Wouter Vervecken , Karen Jacqueline Marcel De Pourcq , Steven Christian Jozef Geysens , Mouna Guerfal
- Applicant: Nico Luc Marc Callewaert , Wouter Vervecken , Karen Jacqueline Marcel De Pourcq , Steven Christian Jozef Geysens , Mouna Guerfal
- Applicant Address: GB Manchester BE Ghent BE Ghent
- Assignee: Oxyrane UK Limited,VIB vzw,Universiteit Gent
- Current Assignee: Oxyrane UK Limited,VIB vzw,Universiteit Gent
- Current Assignee Address: GB Manchester BE Ghent BE Ghent
- Agency: Fish & Richardson P.C.
- Main IPC: C12N9/24
- IPC: C12N9/24 ; C12N9/10 ; C12P21/00 ; C07K14/00 ; C12N9/40 ; C12P21/06 ; A61K38/00
Abstract:
Described herein are methods and genetically engineered cells useful for producing an altered N-glycosylation form of a target molecule. Also described are methods and molecules with altered N-glycosylation useful for treating a variety of disorders such as metabolic disorders.
Public/Granted literature
- US20130195835A1 Glycosylation of Molecules Public/Granted day:2013-08-01
Information query
